Agree with you bottom feeder.
My additional observations to yours ;
1) cash continues to accumulate, however, to deflect from same, they will take another hit on the vendor loan in the December half, a great excuse not to pay A class shareholders again, all that remains to be seen is by how much.
2) stay tuned for an offer to buy back A class shares in March at between $1.00 & $1.20, with a May settlement date ( a few more months of cash accumulation ).
I doubt CMI legal advisers will take this to Court (March), apart from Troy's team taking apart each announcement & prospectus, it is my opinion the Company has gone back on its stated undertakings & intent of the A class shares, plus add in the reason behind offer to convert from ordinary to A's. A commercial judge is going to have a field day with this one.
How the Company is allowed to state it's NTA at $1.69 per ordinary share whilst not false given the wording of the A class prospectus, is definitely misleading when to get to this figure a class of "equity" of approximately 50% of the company's total capital has to be ignored !
ASIC the toothless tiger where are you ?
- Forums
- ASX - By Stock
- a new more exciting year has started!
Agree with you bottom feeder.My additional observations to yours...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECL (ASX) to my watchlist
|
|||||
Last
$3.05 |
Change
-0.020(0.65%) |
Mkt cap ! $88.43M |
Open | High | Low | Value | Volume |
$3.05 | $3.05 | $3.05 | $1.51K | 495 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 716 | $3.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.50 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 716 | 3.050 |
1 | 6645 | 3.010 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
3.500 | 5000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 10.02am 03/07/2024 (20 minute delay) ? |
Featured News
ECL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online